Compare Conflux (CFX) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Conflux vs Enzyme — how do they compare? Conflux trades at Rp751.6 (market cap Rp3,95T, Rp116,89M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Conflux is far larger — about 29449× Enzyme's market cap, and Conflux's circulating supply is 5,2B CFX versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Conflux for 39 Days and Enzyme for 29 Days on average.
| CFX | MLN | |
|---|---|---|
Market Cap | Rp3,95T | Rp134,13M |
Volume (24h) | Rp116,89M | Rp104,56M |
Circulating Supply | 5,2B CFX | 3,3M MLN |
Typical Hold Time | 39 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Conflux is trading at Rp751.6 with a market cap of Rp3.95T, showing bearish technical signals with 14 sell signals versus 2 buys. The asset is consolidating near key support at Rp729-734 with neutral oscillators suggesting limited momentum. No major protocol updates or ecosystem developments have been reported recently, while the 39-day average hold time indicates moderate holding behavior among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks include continued selling pressure and lack of fundamental catalysts. Investors should monitor Rp729 support closely as breach could trigger further declines.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Conflux
Conflux (CFX) is a public layer-1 blockchain that was made to power decentralized applications (dApps), e-commerce, and Web 3.0 infrastructure by being more scalable, decentralized, and secure than existing protocols. Conflux makes it easier to transfer valuable assets by making the process quick, effective, free of network congestion, and with low transaction costs. The platform is based on the Tree-Graph consensus mechanism, and it combines Proof-of-Work (PoW) and Proof-of-Stake (PoS) algorithms to achieve consensus. The protocol uses Turing-complete smart contracts written in Solidity, just like those on Ethereum, and is compatible with the EVM (Ethereum Virtual Machine).
Read more on CFX →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
